https://www.selleckchem.com/pr....oducts/gefitinib-bas
© 2020 S. Karger AG, Basel.INTRODUCTION Regional citrate anticoagulation (RCA) is the recommended anticoagulation modality for continuous renal replacement therapy (CRRT). RCA was associated with a low rate of complications in randomized controlled trials. However, little is known about the type and rate of complications in real life. We sought to describe complications associated with RCA in comparison with those associated with heparin anticoagulation. METHODS In our institution, RCA has been the default anticoagulati
Like
Comment
Share
